---
figid: PMC5759028__onc2017316f8
figlink: /pmc/articles/PMC5759028/figure/fig8/
number: F8
caption: The KRAS/TGF-β/p15Ink4b pathway controls the cell fate. Although oncogenic
  KRAS activates the proliferative signals, it also stimulates the TGF-β expression
  through MEK-EGR1 cascade. TGF-β further activates Cdkn2b expression via Smads component
  of TGF-β pathway. The p15Ink4b encoded by Cdkn2b gene together with p16Ink4a encoded
  by Cdkfn2a inhibit the Rb phosphorylation and activate Rb to induce cellular senescence
  and prevent tumor formation. However, when both Cdkn2a and Cdkn2b are inactivated,
  Rb is phosphorylated by CDK4/6 and make the cells encompass cellular senescence,
  which allow tumor formation.
pmcid: PMC5759028
papertitle: CDKN2B deletion is essential for pancreatic cancer development instead
  of unmeaningful co-deletion due to juxtaposition to CDKN2A.
reftext: Q Tu, et al. Oncogene. 2018 Jan 4;37(1):128-138.
pmc_ranked_result_index: '112709'
pathway_score: 0.9519897
filename: onc2017316f8.jpg
figtitle: KRAS/TGFB/p15Ink4b pathway controls the cell fate
year: '2018'
organisms:
- Homo sapiens
ndex: 7a1d16a2-def2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5759028__onc2017316f8.html
  '@type': Dataset
  description: The KRAS/TGF-β/p15Ink4b pathway controls the cell fate. Although oncogenic
    KRAS activates the proliferative signals, it also stimulates the TGF-β expression
    through MEK-EGR1 cascade. TGF-β further activates Cdkn2b expression via Smads
    component of TGF-β pathway. The p15Ink4b encoded by Cdkn2b gene together with
    p16Ink4a encoded by Cdkfn2a inhibit the Rb phosphorylation and activate Rb to
    induce cellular senescence and prevent tumor formation. However, when both Cdkn2a
    and Cdkn2b are inactivated, Rb is phosphorylated by CDK4/6 and make the cells
    encompass cellular senescence, which allow tumor formation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - E2F2
  - CDKN2A
  - MAP2K2
  - E2F5
  - E2F6
  - RB1
  - KRAS
  - E2F1
  - CDKN2B
  - E2F8
  - EGR1
  - E2F7
  - E2F3
  - E2F4
  - TGFB1
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: P16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: Rb1
  symbol: RB1
  source: hgnc_symbol
  hgnc_symbol: RB1
  entrez: '5925'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: CDKN2B
  symbol: CDKN2B
  source: hgnc_symbol
  hgnc_symbol: CDKN2B
  entrez: '1030'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: EGR1
  symbol: EGR1
  source: hgnc_symbol
  hgnc_symbol: EGR1
  entrez: '1958'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: TGFB1
  symbol: TGFB1
  source: hgnc_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
chemicals: []
diseases: []
figid_alias: PMC5759028__F8
redirect_from: /figures/PMC5759028__F8
figtype: Figure
---
